DERRELL DELOACH: Open Payments
NPI 1548284433 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 29 payments from 16 companies in 2025. Trend: 2023 $1,727 · 2024 $1,549 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 4 | $92 |
| Corcept Therapeutics | 3 | $73 |
| Lilly USA, LLC | 4 | $67 |
| Sequel Med Tech, LLC | 2 | $50 |
| Novo Nordisk Inc | 2 | $49 |
| Dexcom, Inc. | 2 | $45 |
| Mannkind Corporation | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 1 | $35 |
| Amgen Inc. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Korlym, MOUNJARO, TWIIST, Dexcom G6 Transmitter, AFREZZA, TZIELD, EVENITY.
Industry payments across TX — which companies pay providers there.
